$HTFL

Farquhar John C.M. sold $643K of HTFL

Farquhar John C.M. (Chief Executive Officer) sold 22,562 shares of Heartflow, Inc. (HTFL) at $28.50 ($0.64M total) on 2026-06-10 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Farquhar John C.M.
Published Jun 12, 2026, 10:55 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 12, 2026, 10:59 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$HTFL
Neutral
medium confidence
Mentioned
$HTFL
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HTFLNeutralLow
01

Why it matters

The disclosure updates the record of insider activity (CEO direct holdings reduced), but the pre-arranged 10b5-1 plan suggests the sale was scheduled rather than information-driven.

02

Market read

Traders may note insider selling, but the 10b5-1 framing makes it more of a sentiment datapoint than a catalyst.

03

What to watch

The article provides only the sale details; without concurrent buys, guidance changes, or operational updates, the trading signal is weak.

Relevance 4/10Novelty 8/10Timing: Filed 2026-06-12; sale executed 2026-06-10

Background

The article is a primary-source SEC Form 4 insider transaction disclosure for Heartflow, Inc.

Company-level read

Ticker impact

$HTFLNeutralMedium confidence
Context

Heartflow CEO John C.M. Farquhar sold 22,562 shares in an open-market transaction worth $643,017 under a pre-arranged 10b5-1 plan.

Expected impact

Likely limited near-term impact; any reaction should be muted unless accompanied by other company-specific news.

Evidence & confidence

Form 4 insider sales are common and the filing specifies a pre-arranged 10b5-1 plan, reducing the signal of new information.

Market effects

No clear sector read-through; this is company-specific insider transaction data.

None indicated.

None indicated.

Counterpoint

Insider selling under a 10b5-1 plan can be purely mechanical (tax/portfolio rebalancing) and may not reflect bearish expectations.

Key entities

  • Heartflow, Inc.

    Company whose CEO executed an open-market sale disclosed on SEC Form 4.

  • John C.M. Farquhar

    CEO and director who sold 22,562 shares on 2026-06-10.

  • 10b5-1 plan

    Pre-arranged plan cited in the filing, typically reducing interpretive signal.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$HTFLHigh

HTFL Soars After Q2 Beat And Raised 2026 Revenue Outlook

HeartFlow (HTFL) stock rose 9.63% after Q2 earnings beat and raised 2026 revenue outlook. Q2 revenue was $64.08M with 80.1% gross margin, but -55.8% profit margin. Company has strong liquidity with $162.55M cash and low debt. Analysts see near-term support at $46-$47 and resistance at $54-$56, with a 12-month target of $60 if growth continues.

$HTFLMedAI 8/10

Why Heartflow Stock Soared Today

HeartFlow (HTFL) shares rose after the company raised its full-year revenue targets. Revenue grew 48% YoY to $64.1M in Q2, with adjusted gross margin increasing to 83.3%. The company now expects 40-42% revenue growth for 2026, up from prior forecasts. CEO John Farquhar cited improved operating leverage and scalability.